Bladder cancer cells with deficient AGL expression have a higher glycolytic activity and glycine synthesis capacity than those with normal expression of AGL, and this capacity can greatly contribute to the proliferation of bladder cancer (Sun et al., 2019). Here, AGL is linked to urinary bladder cancer.